DMBIO Y
LIVE

Serial Number

79302421

Owner

DM Bio Limited

Attorney

Erica Halstead

Filing Date

Dec 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DMBIO Y Trademark

Serial Number: 79302421 • Registration: 6557534

DMBIO Y is a trademark filed by DM Bio Limited on December 16, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

DM Bio Limited (2 trademarks)

45, Jisikgiban-ro,

Entity Type: 99

Trademark Details

Filing Date

December 16, 2020

Registration Date

November 16, 2021

Published for Opposition

August 31, 2021

Cancellation Date

December 19, 2023

Goods & Services

Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in the treatment of gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, for the treatment of dermatitis, skin pigmentation diseases, and in acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, and in allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer

Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceuticals

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 16, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 16, 2024 DETH
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 22, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 22, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2022 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 6, 2022 FICS
FINAL DISPOSITION PROCESSED
May 6, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 16, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 16, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 31, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 31, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Aug 29, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 11, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 11, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 11, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2021 CNSA
REFUSAL PROCESSED BY IB
Jul 11, 2021 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2021 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 15, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 15, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 10, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 10, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 26, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 22, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 14, 2021 SDRC